How Leading Sponsors Are Redefining Clinical Trial Operations
New IDC research reveals how operational data, site intelligence, and collaboration platforms are helping sponsors accelerate study start-up, reduce risk, and scale with confidence.
Accelerating time to market has never mattered more — yet trial operations teams are under increasing pressure from fragmented systems, manual workflows, and rising regulatory expectations. Study start-up delays, site burnout, and limited operational visibility continue to slow trials and introduce risk across sponsors, CROs, and research sites.
In this IDC Spotlight, life sciences analyst Dr. Nimita Limaye examines how forward-looking organizations are responding to these challenges by modernizing trial operations. Drawing on IDC research and industry benchmarks, the report explores how operational data, site intelligence, and collaborative platforms are reshaping study start-up, oversight, and execution — and what leaders should prioritize next.
What the research highlights
Costly Delays
A single day’s delay can cost up to $500,000 in unrealized drug sales, alongside direct trial costs.
Collaboration Gaps
Over half of life sciences organizations cite unconnected data silos as their top process challenge.
Overwhelmed Sites
Most sites now rely on 20+ systems, driving administrative burden and burnout.
Rising Oversight Expectations
New guidance such as ICH E6(R3) increases the importance of real-time visibility, audit readiness, and sponsor oversight.
Why this matters now
Sponsors and CROs Are Paying Attention
Operational inefficiencies are no longer just a site-level problem. Startup delays, documentation gaps, and limited oversight now directly affect trial timelines, cost, and risk.
As studies become more complex and global, sponsors need better ways to connect operational workflows, data, and teams, without adding to site burden.
Written by Dr. Nimita Limaye, Research VP, Life Sciences R&D Strategy and Technology, IDC
Based on IDC’s ongoing research into clinical trial operations, collaboration, and emerging technology platforms
